International Patent: HYPOIMMUNOGENIC IPS CELL LINES AND USES THEREOF

GENEVA, Aug. 31 -- BOSTON MEDICAL CENTER CORPORATION filed a patent application (US2026/016240) for “HYPOIMMUNOGENIC IPS CELL LINES AND USES THEREOF”. With publication no. WO/2026/178485, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: none

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....